# Protocol for a James Lind Alliance priority setting partnership to identify the most important research priorities addressing respiratory health disparities affecting the Black community in the UK

**Authors:** Kasope Wolffs, Melanie Etti, Ruby Zelzer, Priyanka Punja, Suzannah Kinsella, Erika Kennington, Adewale Adebajo

PMC · DOI: 10.1136/bmjopen-2025-109741 · BMJ Open · 2026-02-02

## TL;DR

This paper outlines a partnership to identify top research priorities for improving respiratory health in the UK's Black community, aiming to reduce health disparities.

## Contribution

The paper introduces a structured partnership to prioritize research addressing racial disparities in respiratory health among Black communities in the UK.

## Key findings

- The Equal Breath PSP will identify 10 top research priorities through stakeholder collaboration.
- The JLA method will be used to gather and prioritize evidence uncertainties from the Black community.
- Findings will be shared with funders and policymakers to promote equity in respiratory health.

## Abstract

Respiratory diseases affect millions of people in the UK, with a disproportionately high burden seen among many marginalised communities. They are the third leading cause of death in the UK and a major driver of morbidity, disability and healthcare service use. Many respiratory conditions cause debilitating symptoms and deterioration in patients’ health and quality of life over time, resulting in substantial increases in National Health Service (NHS) expenditure. Social inequalities, including occupational, housing and environmental disparities, have led to a disproportionate burden of respiratory disease among the Black community. For many Black people living in the UK, respiratory conditions have been under-recognised, misdiagnosed or inadequately treated, further contributing to disparities in health outcomes. Despite the need to address these urgent challenges, research in this area is fragmented and rarely informed by the views and opinions of those most affected. Research prioritisation provides a structured methodology to address this unmet need. The Equal Breath Priority Setting Partnership (PSP) aims to identify the 10 most urgent research priorities in respiratory health for people of Black heritage through meaningful collaboration with people with lived experience of respiratory disease, their caregivers and family members and the healthcare professionals caring for them.

The top 10 research priorities for the Equal Breath PSP will be established using the James Lind Alliance (JLA) method. A steering group comprising approximately 12 people from key stakeholder groups will first be assembled to guide the PSP. Once the context and scope of the PSP has been agreed, the first survey will be developed and disseminated among stakeholder communities to identify evidence uncertainties. Data analysis of the survey responses will create summary questions and critical appraisal of available evidence will verify which of these are evidence gaps. A longlist of approximately 50 summary questions derived from the first survey will be shared with stakeholders in a second shortlisting survey. The highest ranking questions from this survey will be taken into a workshop where the top 10 research priorities will be established through a consensus process.

This PSP employs the JLA methodology, which does not constitute research as defined by the Health Research Authority. Survey respondent data will be stored in accordance with UK General Data Protection Regulation by Asthma+Lung UK. The final 10 research priorities will be shared with funders, policymakers, professional bodies and relevant communities to inform future investment and promote equity in respiratory health.

## Full-text entities

- **Diseases:** non-small cell lung cancer (MESH:D002289), respiratory symptoms (MESH:D012818), idiopathic pulmonary fibrosis (MESH:D054990), infection (MESH:D007239), pulmonary sarcoidosis (MESH:D017565), Asthma (MESH:D001249), respiratory (MESH:D012131), cancer (MESH:D009369), chronic obstructive pulmonary disease (MESH:D029424), Respiratory diseases (MESH:D012140), death (MESH:D003643), cardiovascular disease (MESH:D002318), COVID-19 (MESH:D000086382), Chronic respiratory conditions (MESH:D002908), lung infections (MESH:D012141), PSP (MESH:D020920), long COVID (MESH:D000094024)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12878385/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12878385/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12878385/full.md

---
Source: https://tomesphere.com/paper/PMC12878385